刘新泳山东大学主页平台管理系统--中文主页

科学研究

暂无内容

论文成果 More>>

. Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell, 186, 5347-5362.e24, 2024.
. Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges. DRUG RESISTANCE UPDATES, 73, 2024.
. Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research. Drug Discov Today., 29, 2024.
. Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. SCIENCE TRANSLATIONAL MEDICINE, 15, 2024.
. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023.
黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicianal Chemistry, 64, 13604-13621, 2023.

著作成果 More>>

科研项目 More>>

暂无内容

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..